We further demonstrate that a WR domain mimetic can abrogate TWIST1 activity in vitro, providing further evidence that blocking this interaction and inhibiting TWIST1 expression could be an effective cancer therapeutic strategy. This evidence concerns the gene TWIST1 and cancer.